Atlas Arteria (ALX) Stock Statistics & Valuation Metrics

Atlas Arteria has a market cap or net worth of $7.01B. The enterprise value is AU$8.79B.

Atlas Arteria has 1,450,833,700 shares outstanding. The number of shares has decreased by -2.65% in one year.

Atlas Arteria’s return on equity (ROE) is 0.10 and return on invested capital (ROIC) is -0.10%.

The current PE Ratio of Atlas Arteria is 29.9. Atlas Arteria’s PEG ratio is 4.51.

In the last 12 months, Atlas Arteria had revenue of 145.00M and earned 335.90M in profits. Earnings per share was 0.23.

In the last 12 months, operating cash flow was 431.45M and capital expenditures -900.00K, giving a free cash flow of 430.55M billion.

Atlas Arteria pays an annual dividend of AU$0.2, resulting in a dividend yield of 8.37%

Atlas Arteria upcoming earnings date is Feb 26, 2026, TBA (Confirmed).

Atlas Arteria as a current ratio of 2.73, with Debt / Equity ratio of 27.75%

In the past 12 months, Atlas Arteria has paid 3.10M in taxes.

Atlas Arteria EV to EBITDA ratio is 78.91, with an EV/FCF ratio of 91.08.

Atlas Arteria has $290.40M in cash and marketable securities with $1.70B in debt, giving a net cash position of -$1.41B billion.

Gross margin is 35.83%, with operating margin of -5.59%, and net profit margin of 231.66%.

The average price target for Atlas Arteria is $5.52, which is 11.43% higher than the current price. The consensus rating is Moderate Buy